Xeltis

Xeltis is a medtech company which specializes in vascular implant solutions. From its funding announcement.

€20M UndisclosedRaised 3 months agoEindhoven, NetherlandsHealthcare & MedtechNetherlands
Visit website →

In their own words

What Xeltis says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "medtech company which specializes in vascular implant solutions". Source

Research and developmentCommercial growthManufacturing and scaleRegulatoryUS expansionEuropean expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where Xeltis is today

Xeltis announced a funding round of €20M on 28 July 2026, led by Horizon 3 Healthcare.

Latest round
Undisclosed
Amount
€20M
Announced
28 July 2026
Headquarters
Eindhoven, Netherlands
Sector
Healthcare & Medtech
Growth stage
Growth
Investors
Also participating
Relevant leadership
CEO Eliane Schutte

Momentum AfterRaise intelligence

AfterRaise Score

50
Steady growth
1 funding signal in the last 90 days
Funding recency
28/40
announced within the last 90 days
Round scale
12/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 28 July 2026
    €20M raised
    Led by Horizon 3 Healthcare.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • European market entry
  • US market entry
  • Research programme expansion
  • Scientific team growth

Opportunities this could create

  • Regulatory affairs
  • Quality systems
  • Clinical hiring
  • Provider partnerships
  • Scientific advisers

Based on the Healthcare & Medtech sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Medium momentum7 connected signals
  • 28 July 2026€20M round announced
  • 28 July 2026Stated priority: research and development
  • 28 July 2026Stated priority: commercial growth
  • 28 July 2026Stated priority: manufacturing and scale
  • 28 July 2026Stated priority: regulatory
  • 28 July 2026Stated intent: us expansion AfterRaise intelligence

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Xeltis is open to

Not yet specified

Xeltis has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Xeltis

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Xeltis?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector